Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $36.77 USD
Change Today +1.08 / 3.03%
Volume 1.4M
ACAD On Other Exchanges
As of 5:20 PM 05/6/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Roger G. Mills M.D.

Chief Medical Officer and Executive Vice President of Development, ACADIA Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Dr. Roger G. Mills, M.D. has been an Executive Vice President of Development and Chief Medical Officer at ACADIA Pharmaceuticals Inc. since June 30, 2006. Dr. Mills is responsible for leading ACADIA's global drug development activities. He has more than 18 years of experience in the pharmaceutical industry. He served as Vice President of Development at Pfizer Global R&D, a division of Pfizer Inc., for a five-year period. He was responsible for the management and direction ...

Read Full Background

Corporate Headquarters*

11085 Torreyana Road
San Diego, California 92121

United States

Phone: 858-558-2871
Fax: 858-558-2872

Board Members Memberships*

There is no Board Members Memberships data available.


Charing Cross & Westminster Medical School London

Other Affiliations*

Annual Compensation*

Total Annual Compensation$544,000

Stock Options*

All Other Compensation$13,977
Exercised Options25,000
Exercised Options Value$713,500
Exercisable Options739,034
Unexercisable Options330,001
Total Value of Options$713,500
Total Number of Options1,094,035

Total Compensation*

Total Annual Cash Compensation$557,977
Total Short Term Compensation$544,000
Other Long Term Compensation$13,977
Total Calculated Compensation$3,704,307
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ACAD:US $36.77 USD +1.08


Ron Cohen M.D.Founder, Chief Executive Officer, President and Director
Acorda Therapeutics, Inc.
Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Member of Agenda Committee
Isis Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ACADIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at